XML 10 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Unaudited)
Mar. 31, 2022
USD ($)
Jun. 30, 2021
USD ($)
Current Assets    
Cash and cash equivalents $ 43,636 $ 143,933
Account receivable, net 2,090,909 2,602,392
Advance to suppliers, net 3,097,902
Other receivable 253,083
Loan receivable, net 6,417,350
Total Current Assets 5,485,530 9,163,675
Advance to suppliers - non-current portion 6,257,263
Right of use asset - operating 4,607 2,813
Property and equipment, net 58,180 68,508
Total Assets 11,805,580 9,234,996
Current Liabilities    
Accounts payable 16,043 526,722
Related party loans 19,974
Accrued expenses and other payables 269,069 98,354
Advances and deposits 30,976
Operating lease liabilities 4,607 4,746
Total Current Liabilities 289,719 680,772
Total Liabilities 289,719 680,772
Commitments and Contingencies
Stockholders’ Equity (Deficit)    
Preferred Stock, $0.001 par value, 20,000,000 shares authorized; 50,000 shares and 50,000 shares issued and outstanding at March 31, 2022 and June 30, 2021, respectively 50 50
Common Stock, $0.001 par value, 1,000,000,000 shares authorized; 14,009,945 shares and 14,009,945 shares issued and outstanding at March 31, 2022 and June 30, 2021, respectively 14,010 14,010
Additional paid-in capital 10,535,909 10,515,935
Retained earnings (Accumulated loss) (42,004) (2,796,477)
Accumulated other comprehensive income (loss) 1,007,896 820,706
Total Stockholders’ Equity (Deficit) 11,515,861 8,554,224
Total Liabilities and Stockholders’ Equity $ 11,805,580 $ 9,234,996